Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Merck Just Made a Big Bet on a New Cancer Growth Engine

Merck's $6.7 billion Terns acquisition bolsters its oncology pipeline while reinforcing its strong margins, steadily growing dividend, and long-term growth.

MarketBeat

Unity Soars After Axing a Business, Here's Why

Unity Software's strategic decision to exit its legacy ad business clarifies its growth path, sending a strong signal of renewed focus to Wall Street.

MarketBeat

Coursera's Options Anomaly: A Big Bet on What's Next?

An unusual surge in options trading suggests institutional investors are betting on a significant upward move for Coursera's undervalued stock.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Mastercard's Pivot: A Bullish Strategic Bet on AI and Data

Mastercard's strategic shift from infrastructure to high-growth AI and data services suggests a deliberate focus on a more profitable, technology-driven future.

MarketBeat

Is NuScale's Plunge the Ultimate AI Contrarian Play?

NuScale Power's unique regulatory approvals and rock-solid financial position make it a key player in powering the future of the AI industry.

MarketBeat

The Metals Company: Unlocking a Klondike-Quality Mineral Rush

The Metals Company is a speculative play on the trillion-dollar deep-sea mining industry, on track for regulatory approval within a few quarters.

MarketBeat

3 Investments With Solid Yields Powering Through Market Weakness

As the market sinks deeper into the red, these income-generating investments are performing well with paths toward upside potential ahead.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Is the Explosion of Single-Stock ETFs an Opportunity or a Danger?

Single-stock ETFs can double or even triple the daily returns of a popular underlying stock, but the risks these funds carry should not be overlooked.

MarketBeat

After Falling Nearly 9% Last Week, Has Alphabet Lost Its Edge?

GOOGL fell close to 9% last week but remains the top-performing Magnificent 7 stock over the past 12 months and the only one trading well above its 200-day SMA.

MarketBeat

Three Oversold REITs With Strong Fundamentals

REITs have become a forgotten asset class during the AI boom years, but now that volatility has returned, this sector could be on the verge of a turnaround.

MarketBeat

3 "Tollbooth" Stocks With Hidden Monopolies in Their Industries

Though sometimes not glamorous, tollbooth companies can occupy a special niche that is vital to the functioning of whole industries or sectors.

MarketBeat

MercadoLibre Stock Is in Deep Pullback Territory: Time to Buy?

MercadoLibre (NASDAQ: MELI) has fallen nearly 40% from its all-time high, whilst revenue surged 45% year over year to $8.8 billion in Q4.

MarketBeat

Down 25%, Chinese Giant PDD Could Be a Strong Long-Term Value

See why Chinese e-commerce giant PDD could offer a significant opportunity for long-term investors as shares tank amid a shift in strategy.

MarketBeat

Branch Out With These Multi-Coin Crypto ETFs

Multi-coin ETFs offer access to several cryptocurrencies at once, with a focus on a basket either including or specifically excluding Bitcoin.

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Market Whispers: Is Molson Coors the Next Big Beverage Buyout?

Molson Coors's strategic expansion into high-growth beverage markets and its undervalued stock price position it as a compelling potential acquisition target.

MarketBeat

Target Has Surged in 2026--Wall Street May Be Ready to Hit Pause

Target shares have rallied in 2026 as its turnaround gains traction, but Wall Street may be hitting pause, waiting on clearer signs the strategy is working.

MarketBeat

Blue Owl’s Risk/Reward Profile Is Almost Too Good to Be True

There's a strong argument to be made that Blue Owl’s 65% drop has been completely overcooked, and analysts are calling for as much as 150% upside from here.

MarketBeat

Commercial Metals Stock Price Poised to Slingshot Higher in Q3

Commercial Metals Company is on track to rebound robustly in Q2 and Q3 2026 as its business grows and margins widen. Execution is a risk and a catalyst.

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Russell 2000 Stocks: Too Early or Finally Interesting?

Russell 2000 stocks may be undervalued as rate cuts loom, with ETFs and names like MWA and AAON offering small-cap upside

MarketBeat

Can Capital One Prove Itself in 2026?

Capital One Financial enters 2026 at a critical juncture, as its Discover acquisition and rising credit risks test its ability to deliver sustained growth.

MarketBeat

The Often-Missed Corner of Healthcare That Wall Street Is Loving

Makers of crucial lab equipment and materials for the healthcare industry play a vital, though often overlooked, role for some higher-risk companies.

MarketBeat

Financials Are Down Big This Year, but XLF Is Looking Like a Buy-Low Opportunity

Despite high hopes for financials during Trump’s second term, the sector has performed the worst in the S&P 500 this year. But the XLF offers a buy-low entry.

MarketBeat

Affirm: A Solid Footing or More Volatility Ahead?

Affirm stock is gaining attention as the buy-now-pay-later lender shows growth and improving profitability, but risks remain in credit quality and competition.

MarketBeat

Why It's Not Time to Give Up on the Gold Trade

Gold’s pullback may be temporary as rising U.S. debt, inflation risks, and geopolitical tensions support a longer-term bullish outlook

MarketBeat

Dividend Resilience: Why These Kings Are Safe After a Volatile Q1

In a volatile market, many investors are turning to these Dividend Kings that offer reliable income, strong balance sheets, and stability

1 … 86 87 88 89

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.